Generation of Monoclonal Antibodies against Human Prion Proteins in PrP0/0 Mice
Generation of Monoclonal Antibodies against Human Prion Proteins in PrP0/0 Mice
复制标题
在 PrP0/0 小鼠中产生抗人朊病毒蛋白的单克隆抗体
DOI:
10.1007/bf03401656
复制
发表时间:
1996
影响因子:
5.7
通讯作者:
W. Bodemer
中科院分区:
文献类型:
--
作者:
S. Krasemann;M. Groschup;S. Harmeyer;G. Hunsmann;W. Bodemer
BackgroundPrion diseases belong to a group of neurodegenerative disorders affecting humans and animals. The human diseases indude kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome (GSS), and fatal familial insomnia (FFI). The pathogenic mechanisms of the prion diseases are not yet understood. Monoclonal antibodies provide valuable tools in the diagnosis, as well as in the basic research, of several diseases; however, monospecific antisera or monoclonal antibodies (mAbs) against human prion proteins were, until now, not available.Materials and MethodsWe have developed an immunization protocol based on nucleic acid injection into nontolerant PrP0/0 mice. DNA or RNA coding for different human prion proteins including the mutated sequences associated with CJD, GSS, and FFI were injected into muscle tissue. Mice were primarily inoculated with DNA plasmids encoding the prion protein (PRNP) gene and boosted either with DNA, RNA, or recombinant Semliki Forest Virus particles expressing PRNP. Hybridomas were then prepared.ResultsDifferent mAbs against human prion proteins were obtained, and their binding behavior was analyzed by peptide enzyme-linked immunosorbent assay. Western blot, immunofluorescence, and immunoprecipita-tion. Their cross-reactivity with prion protein from other species was also determined. Our mAbs are directed against four different linear epitopes and may also recognize discontinuous regions of the native prion protein.ConclusionsThese antibodies should allow us to address questions concerning the nature of the prion protein as well as the initiation and progression of prion diseases. Moreover, these mAbs can now be used for the diagnosis of prion diseases of humans and animals.
登录
查看更多内容
DOI:
10.1073/pnas.83.8.2310
发表时间:
1986-04-01
影响因子:
11.1
作者:
MEYER, RK;MCKINLEY, MP;PRUSINER, SB
通讯作者:
PRUSINER, SB
DOI:
10.1073/pnas.85.18.6617
发表时间:
1988-09-01
影响因子:
11.1
作者:
GABIZON, R;MCKINLEY, MP;PRUSINER, SB
通讯作者:
PRUSINER, SB
DOI:
10.1042/bj2660001
发表时间:
1990
期刊:
The Biochemical journal
影响因子:
--
作者:
Gabizon,R;Prusiner,SB
通讯作者:
Prusiner,SB
DOI:
--
发表时间:
1988
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Barry,RA;Vincent,MT;Kent,SB;Hood,LE;Prusiner,SB
通讯作者:
Prusiner,SB
影响因子:
3.7
作者:
XIANG, ZQ;SPITALNIK, S;ERTL, HCJ
通讯作者:
ERTL, HCJ